Navigation Links
Cenix-Designed siRNAs for 95% of Human and Mouse Genomes


siRNA designs now available for >95% of all human and mouse genes listed in RefSeq

Design algorithm developed by Cenix results in highly effective siRNAs

High quality custom siRNA synthesis from The RNA Company

Flexible options -- order individual, pre-designed siRNAs with your choice of synthesis options


Premium Quality siRNA Synthesis
Ambion's custom siRNA service provides the premium quality siRNAs you need for your research. Each siRNA is synthesized in our state-of-the-art chemical synthesis facility to meet the highest quality standards. Our standard purification procedure includes deprotection and column purification, and yields siRNA that is typically 90% pure (guaranteed >80% pure). For the most demanding applications, HPLC and PAGE purification is available, yielding siRNA that is guaranteed >97% pure.

To ensure that we are providing the highest quality siRNA, all HPLC and PAGE purified RNA oligonucleotides are analyzed for purity by capillary electrophoresis (CE) or HPLC. Furthermore, MALDI-TOF (matrix-assisted laser desorption ionization time-of-flight) mass spectrometry is used to analyze the molecular weight of each oligonucleotide (Figure 1). Finally, each annealed siRNA is analyzed by gel or capillary electrophoresis to ensure that the strands annealed properly.

Figure 1. MALDI-TOF Mass Spectrometry Analysis of an HPLC Purified Custom siRNA.


Save Time with Highly Effective, Cenix Designed siRNAs
High quality siRNA is just one aspect of a successful gene silencing experiment. The design of the siRNA sequence is also critical. Ambion has partnered with Cenix BioSciences, which has developed a proprietary siRNA design algorithm that has been refined over the past year to yield an extremely high percentage of effective siRNA sequences (see Designing a Better siRNA). Figure 2 in that article demonstrates the high success rate of the algorithm. In a test of 79 siRNAs designed using the algorithm, 94% (74 of 79) reduced target mRNA levels by at least 70% when assayed 48 hours after transfection. You can now order siRNAs to your gene of interest that have been pre-designed using this algorithm. Multiple designs are immediately available for >95% of all human, mouse, and rat genes listed in the public RefSeq database maintained by NCBI. Ambion and Cenix are committed to continual refinements of the algorithm and corresponding updates to the pre-designed sequences as more is learned about siRNA design and as the RefSeq database is updated.


Complete Flexibility -- Choose One, Two or Three Pre-designed siRNAs Per Gene
To offer you the greatest flexibility in your research, you can have pre-designed siRNAs made at various synthesis scales, with your choice of purification method. Although a single pre-designed siRNA sequence has a high probability of reducing target mRNA levels, independently using two or more siRNAs to the same gene can help confirm the specificity of the siRNA effect. For that reason, Cenix created three designs for >95% of the human, mouse and rat genes in RefSeq. Order one, two, or three of these pre-designed siRNAs per target gene -- the choice is up to you. We can also use the algorithm to design siRNAs to genes in other organisms listed in the NCBI database, or to design siRNAs to target a sequence that you provide. And sequence information is included as part of the product information at no additional cost. Of course, you can also provide us with the siRNA sequence you want synthesized.


A Variety of Synthesis Options to Meet Your Research Goals
A partial list of Ambion's siRNA synthesis scales and purification options is shown below. For information on how to order, click here. (Silencer Validated siRNAs, which have been verified to reduce target gene expression by >70%, are also available.) If you have a custom RNA synthesis project that falls outside the options listed here, please give us a call (1-800-888-8804, option #2) or email us. Our custom synthesis department is ready to work with you to meet your research objectives, no matter what the scope.

Ambion has been granted rights by the Massachusetts Institute of Technology to US Patent Applications 60/265232, 09/821832 and PCT/US01/10188, RNA Sequence-Specific Mediators of RNA Interference.

Designs for pre-designed siRNAs are owned by Cenix and licensed to Ambion.


back to top


Ordering Information
Cat# Product Name Size 16100 Custom siRNA, standard purity 20 nmol 16102 Custom siRNA, standard purity 40 nmol 16104 Custom siRNA, standard purity, annealed 20 nmol 16106 Custom siRNA, standard purity, annealed 40 nmol 16200 Custom siRNA, HPLC purified 40 nmol 16202 Custom siRNA, HPLC purified 160 nmol 16204 Custom siRNA, HPLC purified, annealed 40 nmol 16206 Custom siRNA, HPLC purified, annealed 160 nmol 16300 Custom siRNA, PAGE purified 25 nmol 16304 Custom siRNA, PAGE purified, annealed 25 nmol 16700 Silencer Pre-designed siRNA, standard purity 20 nmol 16702 Silencer Pre-designed siRNA, standard purity 40 nmol 16704 Silencer Pre-designed siRNA, standard purity, annealed 20 nmol 16706 Silencer Pre-designed siRNA, standard purity, annealed 40 nmol 16800 Silencer Pre-designed siRNA, HPLC purified 40 nmol 16802 Silencer Pre-designed siRNA, HPLC purified 160 nmol 16804 Silencer Pre-designed siRNA, HPLC purified, annealed 40 nmol 16806 Silencer Pre-designed siRNA, HPLC purified, annealed 160 nmol 16900 Silencer Pre-designed siRNA, PAGE purified 25 nmol 16904 Silencer Pre-designed siRNA, PAGE purified, annealed 25 nmol
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. Silencer Validated siRNAs
2. Five Ways to Produce siRNAs
3. Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection
4. IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER!
5. Optimizing Chemical Transfection and Electroporation of siRNAs
6. Delivering siRNAs to Difficult Cell Types
7. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
8. Deliver siRNAs Into Primary Cells
9. Optimize Transfection of siRNAs for RNAi
10. RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs
11. Test More siRNAs for Less
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cenix Designed siRNAs for Human and Mouse Genomes

(Date:7/30/2015)... July 30, 2015 AACC welcomed thousands ... 2015 AACC Annual Meeting & Clinical Lab Expo ... 26–30. The meeting showcased revolutionary advancements in clinical ... of healthcare providers to diagnose patients quickly and ... treatment. As of Wednesday, July ...
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative ... study of its canine osteoarthritis stem cell product, currently under development for FDA ... and will be marketed in the US by Aratana. This product, termed AT-016, ...
(Date:7/30/2015)... HIGHLIGHTS:Q2 2015 Results (all changes are against ... were $697 million compared to $701 million in the ... and changes in foreign currency exchange rates decreased sales ... , By business unit, organic sales growth was 6% ... Commercial. , Reported diluted EPS was $0.98 compared ...
(Date:7/29/2015)... 30, 2015 Sanofi, un ... ses résultats pour le premier semestre 2015. Le ... résultats. Visionner l,interview vidéo et lire ... Au sommaire de l,interview :  ... de croissance - Diabète ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... Feb. 11 Elekta Neuromag(R),the world-leading equipment ... (MEG) technology, has been ordered by The,Nebraska ... http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO ), With a reputation ... Nebraska Medical Center has earned J.D. Power ...
... Feb. 11 AtriCure, Inc.,(Nasdaq: ATRC ), ... cardiac surgical,ablation products, today announced that the first ... Dr. Richard Kaplon, a,well-known cardiac surgeon, performed the ... The purpose of the ABLATE clinical trial is ...
... Direct-To-Consumer Campaign of a Living ... ... Inc., the first,company to successfully mass-produce living regenerative medicine products,is ... campaign for a living cell-based therapy. As the first,bio-engineered living ...
Cached Biology Technology:Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medical Center 2Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medical Center 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation 2AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation 4Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 2Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 4
(Date:7/31/2015)... 31 de julio de 2015 La 10 th ... celebrará por medio de BGI del 22 al 25 de octubre ... Este año, la conferencia celebra su décimo aniversario. ... convertido en una de las reuniones anuales más influyentes del ... las reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
(Date:7/30/2015)... MOUNTAIN VIEW, Calif. , July 30, 2015 ... products and services for gene function analysis and ... CRISPR Guide RNA (sgRNA) Knockout Library targeting all ... to specifically and permanently "knock out" a gene,s ... library provides a high throughput screening tool so ...
(Date:7/23/2015)... July 23, 2015 Research and Markets ... the "Global Outlook of the Biometrics Industry ... The global biometrics market is likely ... commercial applications owing to the uptake of multiple ... transformation that enhances the growth of biometrics in ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3
... reasons why early humans the so-called hominins began ... children was a factor, as has previously been suggested. ... cling to their parents in the way that young apes ... explanation as to why humans became bipedal. But University ...
... 2008) Researchers seeking new and more abundant ... have identified a potentially unlimited, noncontroversial, easily collectable, and ... cells - cells that are present in connective tissues ... the uterus. When the fresh growth of tissue and ...
... professor of electrical and computer engineering at McMaster ... Award for his work in electrical, electronic and ... to outstanding scientists and scholars whose fundamental discoveries, ... impact on their own discipline and who are ...
Cached Biology News:Early parents didn't stand for weighty kids 2Menstrual blood -- a valuable source of multipotential stem cells? 2McMaster University engineering professor receives Humboldt Research Award 2
Monocyte-derived dendritic cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Dendritic Cells...
Human plasmacytoid dendritic cells, BDCA-4+, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Human peripheral blood neutrophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Human endothelial progenitor cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Biology Products: